Oxford, England, United Kingdom
Translational and experimental approaches to study immune-mediated diseases, in particular inflammatory bowel diseases. Focus on improving outcome, precision-targeting medicines, and developing alternative therapeutics to treat fibrosis.
Dissecting the cellular and molecular characteristics of inflammation and therapy response in inflammatory bowel disease and arthritis. Focus on Fibroblast Biology.
Epigenetic profiling of pathogenic stromal responses in inflammation at the single-cell level
Therapeutic targeting of fibroblast subsets and their use for drug discovery in Immune-Mediated Inflammatory Diseases
Regulation of IL-17 and IL-36 cytokines at epithelial barrier sites in inflammatory bowel disease and skin inflammation
Tissue engineering group, developing and validating assays for mesenchymal stem cell differentiation and labeling